APO Research

APO RESEARCH · REPORT

Lower Limb Exoskeleton Rehabilitation

Selected research

Industry Research

Lower Limb Exoskeleton Rehabilitation Industry Research Report 2026

Market perspective

The global Lower Limb Exoskeleton Rehabilitation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Lower Limb Exoskeleton Rehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Lower Limb Exoskeleton Rehabilitation is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Lower Limb Exoskeleton Rehabilitation is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Lower Limb Exoskeleton Rehabilitation include Milebot, Hangzhou Taixi Intelligent Technology, Hangzhou Chengtian Technology, Parker Hannifin, Panasonic, Myomo, Marsi Bionics, LockHeed Martin and Lifeward, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Lower Limb Exoskeleton Rehabilitation market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Lower Limb Exoskeleton Rehabilitation Market by Company

Milebot

Hangzhou Taixi Intelligent Technology

Hangzhou Chengtian Technology

Parker Hannifin

Panasonic

Myomo

Marsi Bionics

LockHeed Martin

Lifeward

Hocoma

Ekso Bionics

Cyberdyne

B-TEMIA Inc.

Bionik Laboratories

Alter G

Lower Limb Exoskeleton Rehabilitation Segment by Type

For Adults

For Children

Lower Limb Exoskeleton Rehabilitation Segment by Application

Rehabilitation Center

Family

Other

Lower Limb Exoskeleton Rehabilitation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lower Limb Exoskeleton Rehabilitation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lower Limb Exoskeleton Rehabilitation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lower Limb Exoskeleton Rehabilitation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Lower Limb Exoskeleton Rehabilitation manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Lower Limb Exoskeleton Rehabilitation by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Lower Limb Exoskeleton Rehabilitation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Lower Limb Exoskeleton Rehabilitation Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Lower Limb Exoskeleton Rehabilitation Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Manufacturers (2021-2026) Table 8. Global Lower Limb Exoskeleton Rehabilitation Revenue of Manufacturers (2021-2026) Table 9. Global Lower Limb Exoskeleton Rehabilitation Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Lower Limb Exoskeleton Rehabilitation Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Lower Limb Exoskeleton Rehabilitation Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Lower Limb Exoskeleton Rehabilitation, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Lower Limb Exoskeleton Rehabilitation, Product Type & Application Table 14. Global Lower Limb Exoskeleton Rehabilitation Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Lower Limb Exoskeleton Rehabilitation by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Milebot Company Information Table 19. Milebot Business Overview Table 20. Milebot Lower Limb Exoskeleton Rehabilitation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Milebot Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 22. Milebot Recent Developments Table 23. Hangzhou Taixi Intelligent Technology Company Information Table 24. Hangzhou Taixi Intelligent Technology Business Overview Table 25. Hangzhou Taixi Intelligent Technology Lower Limb Exoskeleton Rehabilitation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Hangzhou Taixi Intelligent Technology Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 27. Hangzhou Taixi Intelligent Technology Recent Developments Table 28. Hangzhou Chengtian Technology Company Information Table 29. Hangzhou Chengtian Technology Business Overview Table 30. Hangzhou Chengtian Technology Lower Limb Exoskeleton Rehabilitation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Hangzhou Chengtian Technology Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 32. Hangzhou Chengtian Technology Recent Developments Table 33. Parker Hannifin Company Information Table 34. Parker Hannifin Business Overview Table 35. Parker Hannifin Lower Limb Exoskeleton Rehabilitation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Parker Hannifin Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 37. Parker Hannifin Recent Developments Table 38. Panasonic Company Information Table 39. Panasonic Business Overview Table 40. Panasonic Lower Limb Exoskeleton Rehabilitation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Panasonic Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 42. Panasonic Recent Developments Table 43. Myomo Company Information Table 44. Myomo Business Overview Table 45. Myomo Lower Limb Exoskeleton Rehabilitation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Myomo Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 47. Myomo Recent Developments Table 48. Marsi Bionics Company Information Table 49. Marsi Bionics Business Overview Table 50. Marsi Bionics Lower Limb Exoskeleton Rehabilitation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Marsi Bionics Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 52. Marsi Bionics Recent Developments Table 53. LockHeed Martin Company Information Table 54. LockHeed Martin Business Overview Table 55. LockHeed Martin Lower Limb Exoskeleton Rehabilitation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. LockHeed Martin Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 57. LockHeed Martin Recent Developments Table 58. Lifeward Company Information Table 59. Lifeward Business Overview Table 60. Lifeward Lower Limb Exoskeleton Rehabilitation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Lifeward Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 62. Lifeward Recent Developments Table 63. Hocoma Company Information Table 64. Hocoma Business Overview Table 65. Hocoma Lower Limb Exoskeleton Rehabilitation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Hocoma Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 67. Hocoma Recent Developments Table 68. Ekso Bionics Company Information Table 69. Ekso Bionics Business Overview Table 70. Ekso Bionics Lower Limb Exoskeleton Rehabilitation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Ekso Bionics Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 72. Ekso Bionics Recent Developments Table 73. Cyberdyne Company Information Table 74. Cyberdyne Business Overview Table 75. Cyberdyne Lower Limb Exoskeleton Rehabilitation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Cyberdyne Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 77. Cyberdyne Recent Developments Table 78. B-TEMIA Inc. Company Information Table 79. B-TEMIA Inc. Business Overview Table 80. B-TEMIA Inc. Lower Limb Exoskeleton Rehabilitation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. B-TEMIA Inc. Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 82. B-TEMIA Inc. Recent Developments Table 83. Bionik Laboratories Company Information Table 84. Bionik Laboratories Business Overview Table 85. Bionik Laboratories Lower Limb Exoskeleton Rehabilitation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Bionik Laboratories Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 87. Bionik Laboratories Recent Developments Table 88. Alter G Company Information Table 89. Alter G Business Overview Table 90. Alter G Lower Limb Exoskeleton Rehabilitation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Alter G Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 92. Alter G Recent Developments Table 93. Global Lower Limb Exoskeleton Rehabilitation Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Lower Limb Exoskeleton Rehabilitation Sales by Region (2021-2026) & (K Units) Table 95. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Region (2021-2026) Table 96. Global Lower Limb Exoskeleton Rehabilitation Sales by Region (2027-2032) & (K Units) Table 97. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Region (2027-2032) Table 98. Global Lower Limb Exoskeleton Rehabilitation Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Region (2021-2026) Table 100. Global Lower Limb Exoskeleton Rehabilitation Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Region (2027-2032) Table 102. North America Lower Limb Exoskeleton Rehabilitation Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2026) & (K Units) Table 104. North America Lower Limb Exoskeleton Rehabilitation Sales by Country (2027-2032) & (K Units) Table 105. North America Lower Limb Exoskeleton Rehabilitation Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Lower Limb Exoskeleton Rehabilitation Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Lower Limb Exoskeleton Rehabilitation Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2026) & (K Units) Table 109. Europe Lower Limb Exoskeleton Rehabilitation Sales by Country (2027-2032) & (K Units) Table 110. Europe Lower Limb Exoskeleton Rehabilitation Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Lower Limb Exoskeleton Rehabilitation Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Lower Limb Exoskeleton Rehabilitation Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2026) & (K Units) Table 114. Asia Pacific Lower Limb Exoskeleton Rehabilitation Sales by Country (2027-2032) & (K Units) Table 115. Asia Pacific Lower Limb Exoskeleton Rehabilitation Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Lower Limb Exoskeleton Rehabilitation Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Lower Limb Exoskeleton Rehabilitation Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2026) & (K Units) Table 119. South America Lower Limb Exoskeleton Rehabilitation Sales by Country (2027-2032) & (K Units) Table 120. South America Lower Limb Exoskeleton Rehabilitation Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Lower Limb Exoskeleton Rehabilitation Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Lower Limb Exoskeleton Rehabilitation Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2026) & (K Units) Table 124. Middle East and Africa Lower Limb Exoskeleton Rehabilitation Sales by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Lower Limb Exoskeleton Rehabilitation Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Lower Limb Exoskeleton Rehabilitation Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Lower Limb Exoskeleton Rehabilitation Sales by Type (2021-2026) & (K Units) Table 128. Global Lower Limb Exoskeleton Rehabilitation Sales by Type (2027-2032) & (K Units) Table 129. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Type (2021-2026) Table 130. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Type (2027-2032) Table 131. Global Lower Limb Exoskeleton Rehabilitation Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Lower Limb Exoskeleton Rehabilitation Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Type (2021-2026) Table 134. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Type (2027-2032) Table 135. Global Lower Limb Exoskeleton Rehabilitation Price by Type (2021-2026) & (US$/Unit) Table 136. Global Lower Limb Exoskeleton Rehabilitation Price by Type (2027-2032) & (US$/Unit) Table 137. Global Lower Limb Exoskeleton Rehabilitation Sales by Application (2021-2026) & (K Units) Table 138. Global Lower Limb Exoskeleton Rehabilitation Sales by Application (2027-2032) & (K Units) Table 139. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Application (2021-2026) Table 140. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Application (2027-2032) Table 141. Global Lower Limb Exoskeleton Rehabilitation Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Lower Limb Exoskeleton Rehabilitation Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Application (2021-2026) Table 144. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Application (2027-2032) Table 145. Global Lower Limb Exoskeleton Rehabilitation Price by Application (2021-2026) & (US$/Unit) Table 146. Global Lower Limb Exoskeleton Rehabilitation Price by Application (2027-2032) & (US$/Unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Lower Limb Exoskeleton Rehabilitation Distributors List Table 150. Lower Limb Exoskeleton Rehabilitation Customers List Table 151. Lower Limb Exoskeleton Rehabilitation Industry Trends Table 152. Lower Limb Exoskeleton Rehabilitation Industry Drivers Table 153. Lower Limb Exoskeleton Rehabilitation Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Lower Limb Exoskeleton Rehabilitation Product Image Figure 5. Global Lower Limb Exoskeleton Rehabilitation Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Lower Limb Exoskeleton Rehabilitation Market Size (2021-2032) & (US$ Million) Figure 7. Global Lower Limb Exoskeleton Rehabilitation Sales (2021-2032) & (K Units) Figure 8. Global Lower Limb Exoskeleton Rehabilitation Average Price (US$/Unit) & (2021-2032) Figure 9. For Adults Product Image Figure 10. For Children Product Image Figure 11. Rehabilitation Center Product Image Figure 12. Family Product Image Figure 13. Other Product Image Figure 14. Global Lower Limb Exoskeleton Rehabilitation Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Lower Limb Exoskeleton Rehabilitation, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Lower Limb Exoskeleton Rehabilitation Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Lower Limb Exoskeleton Rehabilitation Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Lower Limb Exoskeleton Rehabilitation Sales by Region in 2025 Figure 20. Global Lower Limb Exoskeleton Rehabilitation Revenue by Region in 2025 Figure 21. North America Lower Limb Exoskeleton Rehabilitation Market Size by Country in 2025 Figure 22. North America Lower Limb Exoskeleton Rehabilitation Sales Market Share by Country (2021-2032) Figure 23. North America Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Country (2021-2032) Figure 24. United States Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Lower Limb Exoskeleton Rehabilitation Market Size by Country in 2025 Figure 28. Europe Lower Limb Exoskeleton Rehabilitation Sales Market Share by Country (2021-2032) Figure 29. Europe Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Country (2021-2032) Figure 30. Germany Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Lower Limb Exoskeleton Rehabilitation Market Size by Country in 2025 Figure 41. Asia Pacific Lower Limb Exoskeleton Rehabilitation Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Country (2021-2032) Figure 43. China Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Lower Limb Exoskeleton Rehabilitation Market Size by Country in 2025 Figure 52. South America Lower Limb Exoskeleton Rehabilitation Sales Market Share by Country (2021-2032) Figure 53. South America Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Country (2021-2032) Figure 54. Brazil Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Lower Limb Exoskeleton Rehabilitation Market Size by Country in 2025 Figure 58. Middle East and Africa Lower Limb Exoskeleton Rehabilitation Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Country (2021-2032) Figure 60. Egypt Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Lower Limb Exoskeleton Rehabilitation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Type (2021-2032) Figure 66. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Type (2021-2032) Figure 67. Global Lower Limb Exoskeleton Rehabilitation Price (US$/Unit) by Type (2021-2032) Figure 68. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Application (2021-2032) Figure 69. Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Application (2021-2032) Figure 70. Global Lower Limb Exoskeleton Rehabilitation Price (US$/Unit) by Application (2021-2032) Figure 71. Lower Limb Exoskeleton Rehabilitation Value Chain Figure 72. Lower Limb Exoskeleton Rehabilitation Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Lower Limb Exoskeleton Rehabilitation Industry Opportunities and Challenges

Scope & coverage.

Types
  • For Adults
  • For Children
Applications
  • Rehabilitation Center
  • Family
  • Other
Companies covered
  • Milebot
  • Hangzhou Taixi Intelligent Technology
  • Hangzhou Chengtian Technology
  • Parker Hannifin
  • Panasonic
  • Myomo
  • Marsi Bionics
  • LockHeed Martin
  • Lifeward
  • Hocoma
  • Ekso Bionics
  • Cyberdyne
  • B-TEMIA Inc.
  • Bionik Laboratories
  • Alter G

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Lower Limb Exoskeleton Rehabilitation Market Size (2021-2032)
  4. 2.2.2 Global Lower Limb Exoskeleton Rehabilitation Sales (2021-2032)
  5. 2.2.3 Global Lower Limb Exoskeleton Rehabilitation Market Average Price (2021-2032)
  6. 2.3 Lower Limb Exoskeleton Rehabilitation by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 For Adults
  9. 2.3.3 For Children
  10. 2.4 Lower Limb Exoskeleton Rehabilitation by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Rehabilitation Center
  13. 2.4.3 Family
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Lower Limb Exoskeleton Rehabilitation Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Lower Limb Exoskeleton Rehabilitation Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Lower Limb Exoskeleton Rehabilitation Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Lower Limb Exoskeleton Rehabilitation Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Lower Limb Exoskeleton Rehabilitation Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Lower Limb Exoskeleton Rehabilitation, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Lower Limb Exoskeleton Rehabilitation, Product Type & Application
  8. 3.8 Global Manufacturers of Lower Limb Exoskeleton Rehabilitation, Established Date
  9. 3.9 Global Lower Limb Exoskeleton Rehabilitation Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Milebot
  2. 4.1.1 Milebot Company Information
  3. 4.1.2 Milebot Business Overview
  4. 4.1.3 Milebot Lower Limb Exoskeleton Rehabilitation Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Milebot Lower Limb Exoskeleton Rehabilitation Product Portfolio
  6. 4.1.5 Milebot Recent Developments
  7. 4.2 Hangzhou Taixi Intelligent Technology
  8. 4.2.1 Hangzhou Taixi Intelligent Technology Company Information
  9. 4.2.2 Hangzhou Taixi Intelligent Technology Business Overview
  10. 4.2.3 Hangzhou Taixi Intelligent Technology Lower Limb Exoskeleton Rehabilitation Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Hangzhou Taixi Intelligent Technology Lower Limb Exoskeleton Rehabilitation Product Portfolio
  12. 4.2.5 Hangzhou Taixi Intelligent Technology Recent Developments
  13. 4.3 Hangzhou Chengtian Technology
  14. 4.3.1 Hangzhou Chengtian Technology Company Information
  15. 4.3.2 Hangzhou Chengtian Technology Business Overview
  16. 4.3.3 Hangzhou Chengtian Technology Lower Limb Exoskeleton Rehabilitation Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Hangzhou Chengtian Technology Lower Limb Exoskeleton Rehabilitation Product Portfolio
  18. 4.3.5 Hangzhou Chengtian Technology Recent Developments
  19. 4.4 Parker Hannifin
  20. 4.4.1 Parker Hannifin Company Information
  21. 4.4.2 Parker Hannifin Business Overview
  22. 4.4.3 Parker Hannifin Lower Limb Exoskeleton Rehabilitation Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Parker Hannifin Lower Limb Exoskeleton Rehabilitation Product Portfolio
  24. 4.4.5 Parker Hannifin Recent Developments
  25. 4.5 Panasonic
  26. 4.5.1 Panasonic Company Information
  27. 4.5.2 Panasonic Business Overview
  28. 4.5.3 Panasonic Lower Limb Exoskeleton Rehabilitation Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Panasonic Lower Limb Exoskeleton Rehabilitation Product Portfolio
  30. 4.5.5 Panasonic Recent Developments
  31. 4.6 Myomo
  32. 4.6.1 Myomo Company Information
  33. 4.6.2 Myomo Business Overview
  34. 4.6.3 Myomo Lower Limb Exoskeleton Rehabilitation Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Myomo Lower Limb Exoskeleton Rehabilitation Product Portfolio
  36. 4.6.5 Myomo Recent Developments
  37. 4.7 Marsi Bionics
  38. 4.7.1 Marsi Bionics Company Information
  39. 4.7.2 Marsi Bionics Business Overview
  40. 4.7.3 Marsi Bionics Lower Limb Exoskeleton Rehabilitation Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Marsi Bionics Lower Limb Exoskeleton Rehabilitation Product Portfolio
  42. 4.7.5 Marsi Bionics Recent Developments
  43. 4.8 LockHeed Martin
  44. 4.8.1 LockHeed Martin Company Information
  45. 4.8.2 LockHeed Martin Business Overview
  46. 4.8.3 LockHeed Martin Lower Limb Exoskeleton Rehabilitation Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 LockHeed Martin Lower Limb Exoskeleton Rehabilitation Product Portfolio
  48. 4.8.5 LockHeed Martin Recent Developments
  49. 4.9 Lifeward
  50. 4.9.1 Lifeward Company Information
  51. 4.9.2 Lifeward Business Overview
  52. 4.9.3 Lifeward Lower Limb Exoskeleton Rehabilitation Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Lifeward Lower Limb Exoskeleton Rehabilitation Product Portfolio
  54. 4.9.5 Lifeward Recent Developments
  55. 4.10 Hocoma
  56. 4.10.1 Hocoma Company Information
  57. 4.10.2 Hocoma Business Overview
  58. 4.10.3 Hocoma Lower Limb Exoskeleton Rehabilitation Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Hocoma Lower Limb Exoskeleton Rehabilitation Product Portfolio
  60. 4.10.5 Hocoma Recent Developments
  61. 4.11 Ekso Bionics
  62. 4.11.1 Ekso Bionics Company Information
  63. 4.11.2 Ekso Bionics Business Overview
  64. 4.11.3 Ekso Bionics Lower Limb Exoskeleton Rehabilitation Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Ekso Bionics Lower Limb Exoskeleton Rehabilitation Product Portfolio
  66. 4.11.5 Ekso Bionics Recent Developments
  67. 4.12 Cyberdyne
  68. 4.12.1 Cyberdyne Company Information
  69. 4.12.2 Cyberdyne Business Overview
  70. 4.12.3 Cyberdyne Lower Limb Exoskeleton Rehabilitation Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Cyberdyne Lower Limb Exoskeleton Rehabilitation Product Portfolio
  72. 4.12.5 Cyberdyne Recent Developments
  73. 4.13 B-TEMIA Inc.
  74. 4.13.1 B-TEMIA Inc. Company Information
  75. 4.13.2 B-TEMIA Inc. Business Overview
  76. 4.13.3 B-TEMIA Inc. Lower Limb Exoskeleton Rehabilitation Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 B-TEMIA Inc. Lower Limb Exoskeleton Rehabilitation Product Portfolio
  78. 4.13.5 B-TEMIA Inc. Recent Developments
  79. 4.14 Bionik Laboratories
  80. 4.14.1 Bionik Laboratories Company Information
  81. 4.14.2 Bionik Laboratories Business Overview
  82. 4.14.3 Bionik Laboratories Lower Limb Exoskeleton Rehabilitation Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Bionik Laboratories Lower Limb Exoskeleton Rehabilitation Product Portfolio
  84. 4.14.5 Bionik Laboratories Recent Developments
  85. 4.15 Alter G
  86. 4.15.1 Alter G Company Information
  87. 4.15.2 Alter G Business Overview
  88. 4.15.3 Alter G Lower Limb Exoskeleton Rehabilitation Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Alter G Lower Limb Exoskeleton Rehabilitation Product Portfolio
  90. 4.15.5 Alter G Recent Developments
5 Global Lower Limb Exoskeleton Rehabilitation Market Scenario by Region
  1. 5.1 Global Lower Limb Exoskeleton Rehabilitation Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Lower Limb Exoskeleton Rehabilitation Sales by Region: 2021-2032
  3. 5.2.1 Global Lower Limb Exoskeleton Rehabilitation Sales by Region: 2021-2026
  4. 5.2.2 Global Lower Limb Exoskeleton Rehabilitation Sales by Region: 2027-2032
  5. 5.3 Global Lower Limb Exoskeleton Rehabilitation Revenue by Region: 2021-2032
  6. 5.3.1 Global Lower Limb Exoskeleton Rehabilitation Revenue by Region: 2021-2026
  7. 5.3.2 Global Lower Limb Exoskeleton Rehabilitation Revenue by Region: 2027-2032
  8. 5.4 North America Lower Limb Exoskeleton Rehabilitation Market Facts & Figures by Country
  9. 5.4.1 North America Lower Limb Exoskeleton Rehabilitation Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2032)
  11. 5.4.3 North America Lower Limb Exoskeleton Rehabilitation Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Lower Limb Exoskeleton Rehabilitation Market Facts & Figures by Country
  16. 5.5.1 Europe Lower Limb Exoskeleton Rehabilitation Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2032)
  18. 5.5.3 Europe Lower Limb Exoskeleton Rehabilitation Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Lower Limb Exoskeleton Rehabilitation Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Lower Limb Exoskeleton Rehabilitation Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Lower Limb Exoskeleton Rehabilitation Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Lower Limb Exoskeleton Rehabilitation Market Facts & Figures by Country
  41. 5.7.1 South America Lower Limb Exoskeleton Rehabilitation Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2032)
  43. 5.7.3 South America Lower Limb Exoskeleton Rehabilitation Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Lower Limb Exoskeleton Rehabilitation Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Lower Limb Exoskeleton Rehabilitation Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Lower Limb Exoskeleton Rehabilitation Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Lower Limb Exoskeleton Rehabilitation Sales by Type (2021-2032)
  2. 6.1.1 Global Lower Limb Exoskeleton Rehabilitation Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Type (2021-2032)
  4. 6.2 Global Lower Limb Exoskeleton Rehabilitation Revenue by Type (2021-2032)
  5. 6.2.1 Global Lower Limb Exoskeleton Rehabilitation Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Lower Limb Exoskeleton Rehabilitation Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Lower Limb Exoskeleton Rehabilitation Sales by Application (2021-2032)
  2. 7.1.1 Global Lower Limb Exoskeleton Rehabilitation Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Application (2021-2032)
  4. 7.2 Global Lower Limb Exoskeleton Rehabilitation Revenue by Application (2021-2032)
  5. 7.2.1 Global Lower Limb Exoskeleton Rehabilitation Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Lower Limb Exoskeleton Rehabilitation Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Lower Limb Exoskeleton Rehabilitation Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Lower Limb Exoskeleton Rehabilitation Value Chain Analysis
  2. 8.1.1 Lower Limb Exoskeleton Rehabilitation Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Lower Limb Exoskeleton Rehabilitation Production Mode & Process
  5. 8.2 Lower Limb Exoskeleton Rehabilitation Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Lower Limb Exoskeleton Rehabilitation Distributors
  8. 8.2.3 Lower Limb Exoskeleton Rehabilitation Customers
9 Global Lower Limb Exoskeleton Rehabilitation Analyzing Market Dynamics
  1. 9.1 Lower Limb Exoskeleton Rehabilitation Industry Trends
  2. 9.2 Lower Limb Exoskeleton Rehabilitation Industry Drivers
  3. 9.3 Lower Limb Exoskeleton Rehabilitation Industry Opportunities and Challenges
  4. 9.4 Lower Limb Exoskeleton Rehabilitation Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research